✦ LIBER ✦

Study of Aldosterone Synthase Inhibition as an Add-On Therapy in Resistant Hypertension

✍ Scribed by Karns, Adam D.; Bral, Jacqueline M.; Hartman, Daniel; Peppard, Thomas; Schumacher, Christoph

Book ID: 120993610
Publisher: Le Jacq Communications, Inc.
Year: 2012
Tongue: English
Weight: 245 KB
Volume: 15
Category: Article
ISSN: 1524-6175
DOI: 10.1111/jch.12051

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Aldosterone antagonists: effective add-o

Aldosterone antagonists: effective add-on therapy for the treatment of resistant hypertension

✍ Gaddam, Krishna K; Pratt-Ubunama, Monique N; Calhoun, David A 📂 Article 📅 2006 🏛 Expert Reviews 🌐 English ⚖ 135 KB

The Effects of Aldosterone Synthase Inhi

The Effects of Aldosterone Synthase Inhibition on Aldosterone and Cortisol in Patients With Hypertension: A Phase II, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study

✍ Karl Andersen; Daniel Hartman; Thomas Peppard; David Hermann; Peter Van Ess; Mar 📂 Article 📅 2012 🏛 Le Jacq Communications, Inc. 🌐 English ⚖ 331 KB

Huperzine A as add-on therapy in patient

Huperzine A as add-on therapy in patients with treatment-resistant schizophrenia: An open-labeled trial

✍ Zhang-Jin Zhang; Yao Tong; Xue-Yi Wang; Shao-Min Yao; Gui-Xing Jin; Xiao-Ping Wa 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 81 KB

Efficacy of diltiazem er as add-on antih

Efficacy of diltiazem er as add-on antihypertensive therapy in mild to moderate hypertension, and isolated systolic hypertension (the tiara study)

✍ Indravadan M. Dattani; Alexander J. Lang; Jukka K. Karjalainen 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 48 KB

Cochrane Database of Systematic Reviews

Cochrane Database of Systematic Reviews (Reviews) || Calcium antagonists as an add-on therapy for drug-resistant epilepsy

✍ Hasan, Mohammad 📂 Article 📅 2013 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 504 KB

Efficacy and safety evaluation of lorecl

Efficacy and safety evaluation of loreclezole as add-on treatment in therapy-resistant epilepsy patients

✍ T Rentmeester; J Hulsman 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 381 KB

Thirteen drug-resistant epilepsy patients received loreclezole as add-on therapy. The trial lasted 6 months. Loreclezole was dosed to reach a target plasma concentration between 1 and 3 mg/l. The seizure frequency in the total group decreased by 23%. A reduction of 50% or more was observed in four p